Trial Profile
Glycaemic effects of different doses of TAK-875 [fasiglifam] in Japanese patients with type 2 diabetes mellitus inadequately controlled by diet or exercise
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2017
Price :
$35
*
At a glance
- Drugs Fasiglifam (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Feb 2013 New trial record